You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study
|
---|---|
Published in |
Arthritis Research & Therapy, May 2019
|
DOI | 10.1186/s13075-019-1907-x |
Pubmed ID | |
Authors |
Janusz Jaworski, Marco Matucci-Cerinic, Hendrik Schulze-Koops, Maya H. Buch, Eugeniusz J. Kucharz, Yannick Allanore, Arthur Kavanaugh, Philip Young, Goran Babic |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 93 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 10 | 11% |
Researcher | 10 | 11% |
Student > Ph. D. Student | 9 | 10% |
Student > Doctoral Student | 7 | 8% |
Student > Bachelor | 6 | 6% |
Other | 14 | 15% |
Unknown | 37 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 30 | 32% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 12% |
Nursing and Health Professions | 3 | 3% |
Immunology and Microbiology | 2 | 2% |
Neuroscience | 1 | 1% |
Other | 0 | 0% |
Unknown | 46 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2021.
All research outputs
#2,761,534
of 25,385,509 outputs
Outputs from Arthritis Research & Therapy
#560
of 3,381 outputs
Outputs of similar age
#57,183
of 364,187 outputs
Outputs of similar age from Arthritis Research & Therapy
#27
of 66 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,187 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.